Portfolio company
Attomarker
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops point-of-care diagnostic devices that perform rapid, multiplexed blood tests for healthcare providers and pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QuantuMDx
This company develops portable molecular diagnostic platforms and assays for healthcare providers and clinicians to conduct rapid testing at the point of need.
Biosurfit
This company develops and manufactures point-of-care diagnostic blood tests and instruments for healthcare providers and medical device companies.
Highfield Diagnostics
This company develops laser-patterned paper substrates for multiplexed point-of-care diagnostic tests, serving healthcare providers, manufacturers, and individuals requiring self-monitoring for various diseases.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Osler Diagnostics
This company develops portable blood-testing devices that provide laboratory-quality diagnostic results for healthcare providers in various clinical and community settings.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
SpinChip Diagnostics ASA
This company develops and produces a point-of-care platform for medical testing and clinical decisions for healthcare providers and patients.
Abionic
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
